Novartis AG Long Term Debt 2012-2026 | NVS

Novartis AG long term debt for the quarter ending March 31, 2026 was $37.447B, a 72.84% increase year-over-year.

  • Novartis AG long term debt for 2025 was $27.935B, a 30.75% increase from 2024.
  • Novartis AG long term debt for 2024 was $21.366B, a 15.89% increase from 2023.
  • Novartis AG long term debt for 2023 was $18.436B, a 8.93% decline from 2022.

Novartis AG Long Term Debt 2012-2026 | NVS

  • Novartis AG long term debt for 2025 was $27.935B, a 30.75% increase from 2024.
  • Novartis AG long term debt for 2024 was $21.366B, a 15.89% increase from 2023.
  • Novartis AG long term debt for 2023 was $18.436B, a 8.93% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B